These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 10191111)
1. Intracellular trafficking of the JNCL protein CLN3. Haskell RE; Derksen TA; Davidson BL Mol Genet Metab; 1999 Apr; 66(4):253-60. PubMed ID: 10191111 [TBL] [Abstract][Full Text] [Related]
2. Analysis of intracellular distribution and trafficking of the CLN3 protein in fusion with the green fluorescent protein in vitro. Kida E; Kaczmarski W; Golabek AA; Kaczmarski A; Michalewski M; Wisniewski KE Mol Genet Metab; 1999 Apr; 66(4):265-71. PubMed ID: 10191113 [TBL] [Abstract][Full Text] [Related]
3. Localization and processing of CLN3, the protein associated to Batten disease: where is it and what does it do? Pearce DA J Neurosci Res; 2000 Jan; 59(1):19-23. PubMed ID: 10658181 [TBL] [Abstract][Full Text] [Related]
4. CLN6, which is associated with a lysosomal storage disease, is an endoplasmic reticulum protein. Mole SE; Michaux G; Codlin S; Wheeler RB; Sharp JD; Cutler DF Exp Cell Res; 2004 Aug; 298(2):399-406. PubMed ID: 15265688 [TBL] [Abstract][Full Text] [Related]
5. Expression studies of CLN3 protein (battenin) in fusion with the green fluorescent protein in mammalian cells in vitro. Golabek AA; Kaczmarski W; Kida E; Kaczmarski A; Michalewski MP; Wisniewski KE Mol Genet Metab; 1999 Apr; 66(4):277-82. PubMed ID: 10191115 [TBL] [Abstract][Full Text] [Related]
7. Evidence for phosphorylation of CLN3 protein associated with Batten disease. Michalewski MP; Kaczmarski W; Golabek AA; Kida E; Kaczmarski A; Wisniewski KE Biochem Biophys Res Commun; 1998 Dec; 253(2):458-62. PubMed ID: 9878558 [TBL] [Abstract][Full Text] [Related]
8. CLN3 protein regulates lysosomal pH and alters intracellular processing of Alzheimer's amyloid-beta protein precursor and cathepsin D in human cells. Golabek AA; Kida E; Walus M; Kaczmarski W; Michalewski M; Wisniewski KE Mol Genet Metab; 2000 Jul; 70(3):203-13. PubMed ID: 10924275 [TBL] [Abstract][Full Text] [Related]
9. Atrophic macular degeneration mutations in ELOVL4 result in the intracellular misrouting of the protein. Ambasudhan R; Wang X; Jablonski MM; Thompson DA; Lagali PS; Wong PW; Sieving PA; Ayyagari R Genomics; 2004 Apr; 83(4):615-25. PubMed ID: 15028284 [TBL] [Abstract][Full Text] [Related]
10. Posttranslational modification of CLN3 protein and its possible functional implication. Michalewski MP; Kaczmarski W; Golabek AA; Kida E; Kaczmarski A; Wisniewski KE Mol Genet Metab; 1999 Apr; 66(4):272-6. PubMed ID: 10191114 [TBL] [Abstract][Full Text] [Related]
12. A murine model for juvenile NCL: gene targeting of mouse Cln3. Greene ND; Bernard DL; Taschner PE; Lake BD; de Vos N; Breuning MH; Gardiner RM; Mole SE; Nussbaum RL; Mitchison HM Mol Genet Metab; 1999 Apr; 66(4):309-13. PubMed ID: 10191119 [TBL] [Abstract][Full Text] [Related]
13. Novel interactions of CLN3 protein link Batten disease to dysregulation of fodrin-Na+, K+ ATPase complex. Uusi-Rauva K; Luiro K; Tanhuanpää K; Kopra O; Martín-Vasallo P; Kyttälä A; Jalanko A Exp Cell Res; 2008 Sep; 314(15):2895-905. PubMed ID: 18621045 [TBL] [Abstract][Full Text] [Related]
14. Studies of membrane association of CLN3 protein. Kaczmarski W; Wisniewski KE; Golabek A; Kaczmarski A; Kida E; Michalewski M Mol Genet Metab; 1999 Apr; 66(4):261-4. PubMed ID: 10191112 [TBL] [Abstract][Full Text] [Related]
15. Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype. Kwon JM; Rothberg PG; Leman AR; Weimer JM; Mink JW; Pearce DA Neurosci Lett; 2005 Oct; 387(2):111-4. PubMed ID: 16087292 [TBL] [Abstract][Full Text] [Related]
16. Functional expression of GFP-linked human heart sodium channel (hH1) and subcellular localization of the a subunit in HEK293 cells and dog cardiac myocytes. Zimmer T; Biskup C; Dugarmaa S; Vogel F; Steinbis M; Böhle T; Wu YS; Dumaine R; Benndorf K J Membr Biol; 2002 Mar; 186(1):1-12. PubMed ID: 11891584 [TBL] [Abstract][Full Text] [Related]
17. Structure of the CLN3 gene and predicted structure, location and function of CLN3 protein. Mitchison HM; Taschner PE; Kremmidiotis G; Callen DF; Doggett NA; Lerner TJ; Janes RB; Wallace BA; Munroe PB; O'Rawe AM; Gardiner RM; Mole SE Neuropediatrics; 1997 Feb; 28(1):12-4. PubMed ID: 9151311 [TBL] [Abstract][Full Text] [Related]
18. Altered gene expression in the eye of a mouse model for batten disease. Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100 [TBL] [Abstract][Full Text] [Related]
19. A galactosylceramide binding domain is involved in trafficking of CLN3 from Golgi to rafts via recycling endosomes. Persaud-Sawin DA; McNamara JO; Rylova S; Vandongen A; Boustany RM Pediatr Res; 2004 Sep; 56(3):449-63. PubMed ID: 15240864 [TBL] [Abstract][Full Text] [Related]
20. CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide. Puranam KL; Guo WX; Qian WH; Nikbakht K; Boustany RM Mol Genet Metab; 1999 Apr; 66(4):294-308. PubMed ID: 10191118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]